Neuren Pharmaceuticals (NURPF) Short Interest Ratio & Short Volume → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free NURPF Stock Alerts C$12.51 0.00 (0.00%) (As of 05/1/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Neuren Pharmaceuticals Short Interest DataCurrent Short Volume1,184,100 sharesPrevious Short Volume1,187,000 sharesChange Vs. Previous Month-0.24%Dollar Volume Sold Short$14.84 millionShort Interest Ratio / Days to Cover2,960.3Last Record DateApril 15, 2024Today's Trading Volume0 sharesAverage Trading Volume5,256 sharesToday's Volume Vs. Average0% Short Selling Neuren Pharmaceuticals ? Sign up to receive the latest short interest report for Neuren Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNURPF Short Interest Over TimeNURPF Days to Cover Over TimeNURPF Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Neuren Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,184,100 shares C$14.84 million -0.2%N/A2960.3 $12.53 3/31/20241,187,000 shares C$15.97 million +0.3%N/A11870 $13.45 3/15/20241,183,900 shares C$16.57 million +0.1%N/A5919.5 $14.00 2/29/20241,183,000 shares C$14.20 million +0.4%N/A514.3 $12.00 2/15/20241,178,500 shares C$17.51 million +25.2%N/A41.8 $14.86 1/15/2024496,400 shares C$7.68 million +4,036.7%N/A551.6 $15.47 Get the Latest News and Ratings for NURPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neuren Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/202312,000 shares C$203,760.00 +36.4%N/A9.4 $16.98 12/15/20238,800 shares C$97,328.00 -6.4%N/A4.9 $11.06 11/30/20239,400 shares C$93,718.00 -7.8%N/A23.5 $9.97 11/15/202310,200 shares C$91,800.00 -1.0%N/A4.6 $9.00 10/31/202310,300 shares C$67,980.00 +2.0%N/A11.4 $6.60 10/15/202310,100 shares C$73,730.00 No ChangeN/A14.4 $7.30 9/30/202310,100 shares C$74,336.00 -44.8%N/A1.2 $7.36 9/15/202318,300 shares C$134,871.00 -39.2%N/A45.8 $7.37 8/31/202330,100 shares C$254,194.50 -17.1%N/A1.3 $8.45 8/15/202336,300 shares C$286,407.00 -0.8%N/A9.6 $7.89 7/31/202336,600 shares C$350,262.00 +2.8%N/A91.5 $9.57 7/15/202335,600 shares C$327,520.00 +3,136.4%N/A178 $9.20 6/30/20231,100 shares C$8,800.00 -50.0%N/A2.2 $8.00 6/15/20232,200 shares C$19,492.00 +214.3%N/A0.8 $8.86 5/31/2023700 shares C$6,195.00 +250.0%N/A7 $8.85 5/15/2023200 shares C$1,850.00 No ChangeN/A2 $9.25 4/30/2023200 shares C$1,886.00 -33.3%N/A0.5 $9.43 4/15/2023300 shares C$2,682.00 +200.0%N/A1.5 $8.94 3/31/2023100 shares C$911.79 -95.2%N/A0 $9.12 3/15/20232,100 shares C$16,390.50 -66.7%N/A1.1 $7.81 2/28/20236,300 shares C$30,366.00 +215.0%N/A0.4 $4.82 2/15/20232,000 shares C$9,960.20 +150.0%N/A1.3 $4.98 1/31/2023800 shares C$4,392.00 +300.0%N/A0.2 $5.49 1/15/2023200 shares C$1,227.00 No ChangeN/A2 $6.14 12/30/2022200 shares C$1,090.00 -50.0%N/A0 $5.45 12/15/2022400 shares C$1,966.00 -89.2%N/A0.5 $4.92 11/30/20223,700 shares C$20,331.50 +15.6%N/A7.4 $5.50 11/15/20223,200 shares C$18,016.00 +14.3%N/A6.4 $5.63 10/31/20222,800 shares C$13,440.00 -3.5%N/A0.1 $4.80 10/15/20222,900 shares C$12,035.00 -9.4%N/A9.7 $4.15 9/30/20223,200 shares C$13,696.00 +45.5%N/A5.3 $4.28 9/15/20222,200 shares C$9,900.00 +266.7%N/A0.1 $4.50 8/31/2022600 shares C$2,472.00 -73.9%N/A0.8 $4.12 8/15/20222,300 shares C$9,200.00 No ChangeN/A0.2 $4.00Elon’s New Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. NURPF Short Interest - Frequently Asked Questions What is Neuren Pharmaceuticals' current short interest? Short interest is the volume of Neuren Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 1,184,100 shares of NURPF short. Learn More on Neuren Pharmaceuticals' current short interest. What is a good short interest ratio for Neuren Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NURPF shares currently have a short interest ratio of 2,960.0. Learn More on Neuren Pharmaceuticals's short interest ratio. Is Neuren Pharmaceuticals' short interest increasing or decreasing? Neuren Pharmaceuticals saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 1,184,100 shares, a decline of 0.2% from the previous total of 1,187,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Neuren Pharmaceuticals stock? Short selling NURPF is an investing strategy that aims to generate trading profit from Neuren Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Neuren Pharmaceuticals? A short squeeze for Neuren Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NURPF, which in turn drives the price of the stock up even further. How often is Neuren Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NURPF, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ATNFW Short Interest TRSBF Short Interest AGNPF Short Interest DRTSW Short Interest APLMW Short Interest ARTLW Short Interest ASPHF Short Interest ASCLF Short Interest AVCTF Short Interest AWKNF Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NURPF) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics😱 This phenomenon is smashing regular market gainsMillPubDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingForget Nvidia. This is the future of AIPorter & CompanyAI “wealth window” is closing June 25thParadigm Press